Warning: The NCBI web site requires JavaScript to function. more...
Longitudinal microarray analysis of cell surface antigens on peripheral blood mononuclear cells from HIV+ individuals on highly active antiretroviral therapy.
Wu JQ, Dyer WB, Chrisp J, Belov L, Wang B, Saksena NK.
Retrovirology. 2008 Mar 4;5:24.
Related citations
Antibody microarray analysis of cell surface antigens on CD4+ and CD8+ T cells from HIV+ individuals correlates with disease stages.
Wu JQ, Wang B, Belov L, Chrisp J, Learmont J, Dyer WB, Zaunders J, Cunningham AL, Dwyer DE, Saksena NK.
Retrovirology. 2007 Nov 26;4:83.
Relationship between CD38 expression on peripheral blood T-cells and monocytes, and response to antiretroviral therapy: a one-year longitudinal study of a cohort of chronically infected ART-naive HIV-1+ patients.
Almeida M, Cordero M, Almeida J, Orfao A.
Cytometry B Clin Cytom. 2007 Jan 15;72(1):22-33.
HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
Zaccarelli-Filho CA, Ono E, Machado DM, Brunialti M, Succi RC, Salomão R, Kallás EG, de Moraes-Pinto MI.
Cytometry B Clin Cytom. 2007 Jan 15;72(1):14-21.
Differential upregulation of CD38 on different T-cell subsets may influence the ability to reconstitute CD4+ T cells under successful highly active antiretroviral therapy.
Benito JM, López M, Lozano S, Ballesteros C, Martinez P, González-Lahoz J, Soriano V.
J Acquir Immune Defic Syndr. 2005 Apr 1;38(4):373-81.
T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART).
Hazenberg MD, Stuart JW, Otto SA, Borleffs JC, Boucher CA, de Boer RJ, Miedema F, Hamann D.
Blood. 2000 Jan 1;95(1):249-55.
Reconstitution of EBV latent but not lytic antigen-specific CD4+ and CD8+ T cells after HIV treatment with highly active antiretroviral therapy.
Piriou E, Jansen CA, van Dort K, De Cuyper I, Nanlohy NM, Lange JM, van Oers MH, Miedema F, van Baarle D.
J Immunol. 2005 Aug 1;175(3):2010-7.
Dysregulation of CD28 and CTLA-4 expression by CD4 T cells from previously immunodeficient HIV-infected patients with sustained virological responses to highly active antiretroviral therapy.
Stone SF, Price P, French MA.
HIV Med. 2005 Jul;6(4):278-83.
[Evaluation for two-year highly active antiretroviral therapy in Chinese HIV-1 infection patients].
Li H, Zheng YH, Shen Z, Liu M, Liu C, He Y, Chen J, Ou QY, Huang ZL.
Zhonghua Yi Xue Za Zhi. 2007 Nov 13;87(42):2973-6. Chinese.
CD38 expression on CD8 T lymphocytes as a marker of residual virus replication in chronically HIV-infected patients receiving antiretroviral therapy.
Benito JM, López M, Lozano S, Martinez P, González-Lahoz J, Soriano V.
AIDS Res Hum Retroviruses. 2004 Feb;20(2):227-33.
Cd38 expression on Cd8+ T cells in Human immunodeficiency virus 1-positive adults treated with HAART.
Beran O, Holub M, Spála J, Kalanin J, Stanková M.
Acta Virol. 2003;47(2):121-4.
Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers.
Messele T, Brouwer M, Girma M, Fontanet AL, Miedema F, Hamann D, Rinke de Wit TF.
Clin Immunol. 2001 Feb;98(2):212-9.
The dominant source of CD4+ and CD8+ T-cell activation in HIV infection is antigenic stimulation.
Cohen Stuart JW, Hazebergh MD, Hamann D, Otto SA, Borleffs JC, Miedema F, Boucher CA, de Boer RJ.
J Acquir Immune Defic Syndr. 2000 Nov 1;25(3):203-11.
Limited long-term naive CD4+ T cell reconstitution in patients experiencing viral load rebounds during HAART.
Choremi-Papadopoulou H, Tsalimalma K, Dafni U, Dimitracopoulou A, Kordossis T.
J Med Virol. 2004 Jun;73(2):235-43.
CD4(+) T-cell immunodeficiency is more dependent on immune activation than viral load in HIV-infected children on highly active antiretroviral therapy.
Resino S, Seoane E, Gutiérrez MD, León JA, Muñoz-Fernández MA.
J Acquir Immune Defic Syndr. 2006 Jul;42(3):269-76.
Changes of lymphocyte apoptosis associated with sequential introduction of highly active antiretroviral therapy.
Wasmuth JC, Hackbarth F, Rockstroh JK, Sauerbruch T, Spengler U.
HIV Med. 2003 Apr;4(2):111-9.
Immunologic features of HIV-1-infected women on HAART at delivery.
Ono E, Dos Santos AM, Machado DM, Succi RC, Amed AM, Salomão R, Kallás EG, de Moraes-Pinto MI.
Cytometry B Clin Cytom. 2008 Jul;74(4):236-43.
T cell receptor excision circle (TREC) content following maximum HIV suppression is equivalent in HIV-infected and HIV-uninfected individuals.
Steffens CM, Smith KY, Landay A, Shott S, Truckenbrod A, Russert M, Al-Harthi L.
AIDS. 2001 Sep 28;15(14):1757-64.
Short- and long-term effects of highly active antiretroviral therapy on Kaposi sarcoma-associated herpesvirus immune responses and viraemia.
Bourboulia D, Aldam D, Lagos D, Allen E, Williams I, Cornforth D, Copas A, Boshoff C.
AIDS. 2004 Feb 20;18(3):485-93.
[Abnormal changes of CD28 expression on CD4 + T cells in treatment-näive and highly active antiretroviral therapy-treated HIV/AIDS patients].
Xie J, Han Y, Li TS, Qiu ZF, Zuo LY, Li YL, Wang AX.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2006 Oct;28(5):618-21. Chinese.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on